|
1
|
Danaei G, Vander Hoorn S, Lopez AD, Murray
CJ and Ezzati M; Comparative Risk Assessment collaborating group
(Cancers). Causes of cancer in the world: comparative risk
assessment of nine behavioural and environmental risk factors.
Lancet. 366:1784–1793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Catalano V, Labianca R, Beretta GD, Gatta
G, de Braud F and Van Cutsem E: Gastric cancer. Crit Rev Oncol
Hematol. 71:127–164. 2009. View Article : Google Scholar
|
|
3
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
4
|
Chen JG, Zhu J, Parkin DM, et al: Trends
in the incidence of cancer in Qidong, China, 1978–2002. Int J
Cancer. 119:1447–1454. 2006.PubMed/NCBI
|
|
5
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
|
6
|
Correa P, Haenszel W, Cuello C, Tannenbaum
S and Archer M: A model for gastric cancer epidemiology. Lancet.
2:58–60. 1975. View Article : Google Scholar
|
|
7
|
de Vries AC, van Grieken NC, Looman CW, et
al: Gastric cancer risk in patients with premalignant gastric
lesions: a nationwide cohort study in the Netherlands.
Gastroenterology. 134:945–952. 2008.PubMed/NCBI
|
|
8
|
Kim HJ, Choi BY, Byun TJ, et al: The
prevalence of atrophic gastritis and intestinal metaplasia
according to gender, age and Helicobacter pylori infection
in a rural population. J Prev Med Public Health. 41:373–379.
2008.(In Korean).
|
|
9
|
Sbrozzi-Vanni A, Zullo A, Di Giulio E, et
al: Low prevalence of idiopathic peptic ulcer disease: an Italian
endoscopic survey. Dig Liver Dis. 42:773–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malfertheiner P, Chan FK and McColl KE:
Peptic ulcer disease. Lancet. 374:1449–1461. 2009. View Article : Google Scholar
|
|
11
|
Malfertheiner P, Megraud F, O’Morain CA,
et al; European Helicobacter Study Group. Management of
Helicobacter pylori infection - the Maastricht IV/Florence
Consensus Report. Gut. 61:646–664. 2012.
|
|
12
|
Lv SX, Gan JH, Wang CC, et al: Biopsy from
the base of gastric ulcer may find gastric cancer earlier. Med
Hypotheses. 76:249–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Molloy RM and Sonnenberg A: Relation
between gastric cancer and previous peptic ulcer disease. Gut.
40:247–252. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eidt S and Stolte M: Prevalence of
intestinal metaplasia in Helicobacter pylori gastritis.
Scand J Gastroenterol. 29:607–610. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leung WK, Lin SR, Ching JY, et al: Factors
predicting progression of gastric intestinal metaplasia: results of
a randomised trial on Helicobacter pylori eradication. Gut.
53:1244–1249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsukui T, Kashiwagi R, Sakane M, et al:
Aging increases, and duodenal ulcer reduces the risk for intestinal
metaplasia of the gastric corpus in Japanese patients with
dyspepsia. J Gastroenterol Hepatol. 16:15–21. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hansson LE, Nyrén O, Hsing AW, et al: The
risk of stomach cancer in patients with gastric or duodenal ulcer
disease. N Engl J Med. 335:242–249. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cho SJ, Choi IJ, Kim CG, et al: Risk
factors associated with gastric cancer in patients with a duodenal
ulcer. Helicobacter. 15:516–523. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Drossman DA: The functional
gastrointestinal disorders and the Rome II process. Gut. 45(Suppl
2): II1–II5. 1999.PubMed/NCBI
|
|
20
|
Xia HH, Wong BC, Wong KW, et al: Clinical
and endoscopic characteristics of non-Helicobacter pylori,
non-NSAID duodenal ulcers: a long-term prospective study. Aliment
Pharmacol Ther. 15:1875–1882. 2001.
|
|
21
|
Dixon MF, Genta RM, Yardley JH and Correa
P: Classification and grading of gastritis. The updated Sydney
System International Workshop on the Histopathology of Gastritis,
Houston 1994. Am J Surg Pathol. 20:1161–1181. 1996.PubMed/NCBI
|
|
22
|
Torpy JM, Lynm C and Golub RM: JAMA
patient page. Peptic ulcer disease. JAMA. 307:13292012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aro P, Storskrubb T, Ronkainen J, et al:
Peptic ulcer disease in a general adult population: the Kalixanda
study: a random population-based study. Am J Epidemiol.
163:1025–1034. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bao Y, Spiegelman D, Li R, Giovannucci E,
Fuchs CS and Michaud DS: History of peptic ulcer disease and
pancreatic cancer risk in men. Gastroenterology. 138:541–549. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z, Zou D, Ma X, et al: Epidemiology of
peptic ulcer disease: endoscopic results of the systematic
investigation of gastrointestinal disease in China. Am J
Gastroenterol. 105:2570–2577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rauws EA and Tytgat GN: Cure of duodenal
ulcer associated with eradication of Helicobacter pylori.
Lancet. 335:1233–1235. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Malfertheiner P, Leodolter A and Peitz U:
Cure of Helicobacter pylori-associated ulcer disease through
eradication. Baillieres Best Pract Res Clin Gastroenterol.
14:119–132. 2000.
|
|
28
|
Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB and
Lin JT: Early Helicobacter pylori eradication decreases risk
of gastric cancer in patients with peptic ulcer disease.
Gastroenterology. 137:1641–1648.e2. 2009.
|
|
29
|
Shimizu S, Nakamura S, Kishino M, Konishi
H and Shiratori K: Role of antithrombotic therapy and nonsteroidal
anti-inflammatory drug use in bleeding gastroduodenal ulcers.
Intern Med. 48:631–637. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Konturek SJ, Bielański W, Płonka M, et al:
Helicobacter pylori, non-steroidal anti-inflammatory drugs
and smoking in risk pattern of gastroduodenal ulcers. Scand J
Gastroenterol. 38:923–930. 2003. View Article : Google Scholar
|
|
31
|
Arkkila PE, Seppälä K, Kosunen TU, et al:
Helicobacter pylori eradication as the sole treatment for
gastric and duodenal ulcers. Eur J Gastroenterol Hepatol.
17:93–101. 2005. View Article : Google Scholar
|
|
32
|
Dinis-Ribeiro M, Areia M, de Vries AC, et
al: Management of precancerous conditions and lesions in the
stomach (MAPS): guideline from the European Society of
Gastrointestinal Endoscopy (ESGE), European Helicobacter Study
Group (EHSG), European Society of Pathology (ESP), and the
Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy.
44:74–94. 2012.
|
|
33
|
Yee YK, Wong KW, Hui CK, et al: Prevalence
and time trend of intestinal metaplasia in Hong Kong. J
Gastroenterol Hepatol. 24:896–899. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Van Zanten SJ, Dixon MF and Lee A: The
gastric transitional zones: neglected links between gastroduodenal
pathology and Helicobacter ecology. Gastroenterology.
116:1217–1229. 1999.PubMed/NCBI
|
